Literature DB >> 1283078

Massive abdominal lymphadenopathy in hairy cell leukaemia: a report of 12 cases.

J Mercieca1, E Matutes, E Moskovic, K MacLennan, F Matthey, C Costello, J Behrens, S Basu, S Roath, S Fairhead.   

Abstract

Lymphadenopathy is an uncommon finding in hairy cell leukaemia (HCL). We report 12 HCL patients in whom relapse was associated with massive abdominal lymphadenopathy. All but one had long-standing HCL (range 3-25 years; median 10 years); in one it was discovered at presentation. Nine patients had been splenectomized and seven had previously been treated with 2'deoxycoformycin (DCF) and/or alpha-interferon (alpha IFN): three had achieved complete remission and four a partial response. The computerized tomography (CT) scan appearances were similar in all cases with a primary lymph node mass centred around the coeliac axis and involving upper para-aortic and retropancreatic regions. Histology and/or cytology confirmed nodal involvement by HCL in six patients. Large immature hairy cells were seen in both lymph nodes and bone marrow, suggesting a degree of transformation. Nine patients were treated with DCF: one had complete resolution, six responded with 50-90% reduction of the lymphadenopathy, one did not respond and one is still on treatment; alpha-IFN was used concomitantly or sequentially in two of the responders. One responding patient died of sepsis after four injections of DCF. Three patients received either alpha- or beta-IFN alone with no response. One elderly patient was not treated. Abdominal lymphadenopathy could be part of the natural history of HCL and/or may represent a transformation analogous to that seen in other low-grade lymphoproliferative disorders. Routine abdominal CT scanning should be part of the work up of all patients with HCL.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1283078     DOI: 10.1111/j.1365-2141.1992.tb06465.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  3 in total

1.  Tumorous manifestation of hairy cell leukemia after long-term treatment with interferon alpha.

Authors:  D Huhn; J Oertel; S Serke; D Kaiser; A Schmitt-Gräff; H Stein
Journal:  Ann Hematol       Date:  1995-02       Impact factor: 3.673

2.  VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy.

Authors:  Evgeny Arons; Tara Suntum; Maryalice Stetler-Stevenson; Robert J Kreitman
Journal:  Blood       Date:  2009-09-10       Impact factor: 22.113

3.  Marked retroperitoneal lymphadenopathy in hairy cell leukemia: a case report.

Authors:  R E Shackelford; M Heldmann; F Eskandari; N Joshi; J Browning; N Maxwell; J Coteligam
Journal:  Case Rep Oncol       Date:  2013-09-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.